Literature DB >> 142124

Further studies on the activation of influenza virus by proteolytic cleavage of the haemagglutinin.

H D Klenk, R Rott, M Orlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 142124     DOI： 10.1099/0022-1317-36-1-151

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


× No keyword cloud information.
  27 in total

1.  Cleavage of influenza A virus H1 hemagglutinin by swine respiratory bacterial proteases.

Authors:  R J Callan; F A Hartmann; S E West; V S Hinshaw
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Inability of real-time reverse transcriptase PCR assay to detect subtype H7 avian influenza viruses isolated from wild birds.

Authors:  Zheng Xing; Carol Cardona; Phuong Dao; Beate Crossley; Sharon Hietala; Walter Boyce
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

Review 3.  Molecular basis of infectivity and pathogenicity of myxovirus. Brief review.

Authors:  R Rott
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33.

Authors:  A C Ward; T F de Koning-Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Protective effect of protease inhibitors in influenza virus infected animals.

Authors:  O P Zhirnov; A V Ovcharenko; A G Bukrinskaya
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Viral glycoproteins as determinants of pathogenicity.

Authors:  H D Klenk; W Garten; F X Bosch; R Rott
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

7.  Effects of various proteases on the glycoprotein composition and the infectivity of influenza C virus.

Authors:  K Sugawara; M Ohuchi; K Nakamura; M Homma
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 8.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

9.  Interference with glycosylation of glycoproteins. Inhibition of formation of lipid-linked oligosaccharides in vivo.

Authors:  R Datema; R T Schwarz
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

10.  A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.

Authors:  John Steel; Svetlana V Burmakina; Colleen Thomas; Erica Spackman; Adolfo García-Sastre; David E Swayne; Peter Palese
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.